ALZM is our first medical pick this year!
PennyStockGains Newsletter
Hi Everyone, For our new subscribers, Welcome! We have received several emails regarding the newsletter we sent earlier today announcing our new pick… Members are saying that they are experiencing issues accessing the link in the newsletter so we will announce this new pick in the traditional format.
Our new pick is ALZM ALZM is steadily climbing every day and is already up almost 3X ALZM could be headed to $20 a share according to smallcapfortunes ALZM has startling technology that has attracted our attention ALZM could be according to smallcapfortunes a huge target for a buyout by Johnson&Johnson, Siemens and many more Short-sellers are possibly holding a very large short position which once they are forced to cover could catapult the shareprice very high! ALZM could seriously be one of the best medical plays we have seen in history.
ALZM announced that they are preparing for clinical trials.
Clinical trials for medical devices can typically be MUCH faster than pharmaceutical trials because the FDA does not necessarily require any testing on animals or humans.
Should they get approval by the FDA this thing could totally blow out of proportions! Also on the ALZMboards…Gene Pearce, who is considered the patriarch of organ transplant in the US. Pearce is the founder and Chairman Emeritus of the United Network for Organ Sharing (UNOS), the quasi-governmental body that regulates organ transplantation in the US and controls the highly restricted wait list. His association with ALZM should help fast-track FDA approval.
We will be sending out a much more detailed and informative newsletter this evening in the meantime ALZMdefinitely deserves our attention! Let`s add ALZM to our watch list immediately! Happy Trading! Your PennyStockGains Editor.
This message was sent to from:
92315563 | 2885 Sanford Ave SW #12529 | GrandVille, MI 49418
Related posts: